CLINICAL_TRIALS
research
· 2025-09-10
Clinical Trial Update: A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia [Phase 2]
Summary
A Phase 2 clinical study evaluating the efficacy and safety of HRS-7249 for hyperlipidemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Hyperlipidemia | Phase 2 | Status: RECRUITING